1Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med,2002,346:92.
2Francesco Grossi,Marianna Aita,Carlotta Defferrari,et al.Impact of third-Generation drugs on the activity of first -line chemotherapy in advanced non -Small cell lung cancer:A meta -analytical approach.Oncologist,2009,14:497.
3Scagliotti GV,Parikh P,von Pawel J,et al.Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy -naive patients with advanced -stage NSCLC.J Clin Oncol,2008,26(21):3543.
5Kim ES,Hirsch V,Mok T,et al.Gefi-tinib versus docetaxel in pre-viously treat -ed non-small -cell lung cancer (INTEREST):a ran-domised phase III trial.Lancet,2008,372:1809.
6Tony S,K.Mok,Yi -Long Wu,FACS,et al.IPASS:Gefitinib or carbo-platin -paclitaxel in pulmonary adenocarcinoma.N Engl J Med,2009,361:947.
7Sandler A,Gray R,Perry MC,et al.Paclitaxel-carboplatin alone or with bevacizumab for non -small -cell lung cancer.N Engl J Med,2006,355:2542.
8Martin Reck,Joachim von Pawel,Petr Zatloukal,et al.Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first -line therapy for nonsquamous non -small -cell lung cancer:AVAiL.J Clin Oncol,27:1227.
9Pirker R,Periera JR,Szczesna A,et al.Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX):an open label randomised phase III trial.Lancet,2009,373:1525.
10Gatzemeier U,von Pawel J,Vynnychenko I,et al.FLEX:cetux-imab in combination with platinum-based chemotherapy (CT)im-proves survival versus CT alone in the 1st-line treatment of patients (pts)with advanced non-small cell lung cancer (NSCLC).J Thorac Oncol,2008,3:S265.
3Ozdemir OL, Ozdemir P, Veral A, et al. ERCC 1 expression does not predict survival and treatment response in advanced stage non- small cell lung cancer cases treated with platinum based chemotherapy [J]. Asian Pac J Cancer Prey,2013,14 (8):4679- 4683.
4Duffaud F,Therasse P. New guide|ines to evaluate the response to treatment in solid tumors[J]. Bull Cancer, 2000,87(12) : 881-886.
5Perrone F, Nuzzo F, Di R F, et al.Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase II ELDA trial[J].Ann Oncol, 2014, 26 (4) : 675-682.
